Price (delayed)
$23.02
Market cap
$2.86B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.25
Enterprise value
$2.77B
Olink Holding AB provides accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients.
There are no recent dividends present for OLK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.